Immune Design Corp. Company Profile (NASDAQ:IMDZ)

About Immune Design Corp.

Immune Design Corp. logoImmune Design Corp. is a clinical stage immunotherapy company. The Company focuses on cancer with in vivo approaches designed to enable the body's immune system to fight disease. The Company is developing multiple product candidates from its discovery platforms, including ZVex and GLAAS. ZVex is a discovery platform that uses a vector to generate product candidates designed to create cytotoxic T cells (CTLs) in vivo. The ZVex vector is a delivery system based on a hybrid, re-engineered virus designed to carry the genetic information of selected tumor antigen in whole or selected epitopes selectively to dendritic cells (DCs) in the skin. When injected into a cancer patient, a ZVex-based product candidate is designed to interact only with these DCs, delivering the tumor antigen in the form of ribonucleic acid (RNA). GLA Adjuvant Systems (GLAAS) is a discovery platform that works in vivo and is based on a synthetic molecule called glucopyranosyl lipid A (GLA).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: IMDZ
  • CUSIP:
Key Metrics:
  • Previous Close: $7.58
  • 50 Day Moving Average: $7.11
  • 200 Day Moving Average: $10.08
  • 52-Week Range: $6.02 - $23.55
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.68
  • P/E Growth: -0.60
  • Market Cap: $152.93M
  • Outstanding Shares: 20,175,000
  • Beta: 2.67
Profitability:
  • Net Margins: -525.30%
  • Return on Equity: -44.57%
  • Return on Assets: -41.51%
Debt:
  • Current Ratio: 9.13%
  • Quick Ratio: 9.06%
Additional Links:
Companies Related to Immune Design Corp.:

Analyst Ratings

Consensus Ratings for Immune Design Corp. (NASDAQ:IMDZ) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $17.00 (124.27% upside)

Analysts' Ratings History for Immune Design Corp. (NASDAQ:IMDZ)
Show:
DateFirmActionRatingPrice TargetDetails
8/10/2016Jefferies GroupReiterated RatingBuy$20.00 -> $17.00View Rating Details
6/10/2016Leerink SwannReiterated RatingBuyView Rating Details
5/11/2016Wells Fargo & Co.Reiterated RatingBuyView Rating Details
5/11/2016Cowen and CompanyReiterated RatingBuyView Rating Details
(Data available from 10/1/2014 forward)

Earnings

Earnings History for Immune Design Corp. (NASDAQ:IMDZ)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2016        
8/9/2016Q2($0.68)($0.71)ViewN/AView Earnings Details
5/10/2016Q1($0.62)($0.61)ViewListenView Earnings Details
3/10/2016Q4($0.54)($0.60)$1.06 million$1.10 millionViewListenView Earnings Details
11/12/2015Q315($0.39)($0.37)$4.10 million$4.70 millionViewListenView Earnings Details
8/12/2015Q215($0.47)($0.54)$1.71 millionViewListenView Earnings Details
5/14/2015Q115($0.64)($0.56)$1.30 million$1.90 millionViewListenView Earnings Details
3/31/2015($0.68)($0.78)ViewListenView Earnings Details
11/12/2014Q3 14($0.36)($0.55)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Immune Design Corp. (NASDAQ:IMDZ)
Current Year EPS Consensus Estimate: $-2.7 EPS
Next Year EPS Consensus Estimate: $-2.83 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.56)($0.56)($0.56)
Q2 20162($0.75)($0.63)($0.69)
Q3 20162($0.72)($0.66)($0.69)
Q4 20162($0.68)($0.61)($0.65)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Immune Design Corp. (NASDAQ:IMDZ)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Immune Design Corp. (NASDAQ:IMDZ)
Insider Ownership Percentage: 42.90%
Institutional Ownership Percentage: 38.81%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/20/2016Group L P ColumnMajor ShareholderBuy800,000$6.25$5,000,000.00View SEC Filing  
9/20/2016Lewis W ColemanDirectorBuy40,000$6.25$250,000.00View SEC Filing  
7/15/2016Stephen R BradyEVPBuy1,500$6.84$10,260.00View SEC Filing  
11/23/2015Wayne GombotzinsiderSell5,000$20.00$100,000.00View SEC Filing  
9/14/2015Wayne GombotzinsiderSell5,000$16.19$80,950.00View SEC Filing  
8/25/2015Lewis W ColemanDirectorBuy3,000$14.50$43,500.00View SEC Filing  
5/12/2015Proquest Investments Iv, L.P.Major ShareholderSell177,607$21.60$3,836,311.20View SEC Filing  
4/24/2015Proquest Investments Iv, L.P.Major ShareholderSell82,892$26.81$2,222,334.52View SEC Filing  
4/21/2015Franklin M BergerDirectorBuy25,000$26.50$662,500.00View SEC Filing  
4/21/2015Proquest Investments Iv, L.P.Major ShareholderSell45,820$26.51$1,214,688.20View SEC Filing  
4/16/2015Proquest Investments Iv, L.P.Major ShareholderSell53,914$28.23$1,521,992.22View SEC Filing  
4/7/2015Proquest Investments Iv, L.P.Major ShareholderSell7,495$26.72$200,266.40View SEC Filing  
3/25/2015Proquest Investments Iv, L.P.Major ShareholderSell18,156$27.64$501,831.84View SEC Filing  
3/23/2015Proquest Investments Iv, L.P.Major ShareholderSell44,464$27.52$1,223,649.28View SEC Filing  
3/18/2015Proquest Investments Iv, L.P.Major ShareholderSell50,309$26.09$1,312,561.81View SEC Filing  
3/12/2015Proquest Investments Iv, L.P.Major ShareholderSell129,342$24.94$3,225,789.48View SEC Filing  
3/9/2015Proquest Investments Iv, L.P.Major ShareholderSell39,446$25.45$1,003,900.70View SEC Filing  
7/29/2014Alta Partners Viii, L.P.Major ShareholderBuy299,559$12.00$3,594,708.00View SEC Filing  
7/29/2014Franklin M BergerDirectorBuy50,000$12.00$600,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Immune Design Corp. (NASDAQ:IMDZ)
DateHeadline
streetinsider.com logoImmune Design's (IMDZ) GLAAS Discovery Platform Utilized in Sanofi Phase 1 for Peanut Allergy Therapy (NASDAQ:IMDZ)
www.streetinsider.com - September 29 at 5:34 PM
publicnow.com logoImmune Design Announces Advancement of First GLAAS™-based Allergy Program into Clinical Development (NASDAQ:IMDZ)
www.publicnow.com - September 28 at 10:28 AM
4-traders.com logoThursday 9/22 Insider Buying Report: IMDZ, AMBC (NASDAQ:IMDZ)
www.4-traders.com - September 22 at 3:39 PM
nasdaq.com logoImmune Design Prices Public Offering of Common Stock (NASDAQ:IMDZ)
www.nasdaq.com - September 16 at 5:29 PM
biz.yahoo.com logoIMMUNE DESIGN CORP. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statement (NASDAQ:IMDZ)
biz.yahoo.com - September 16 at 5:29 PM
4-traders.com logoImmune Design : Prices Public Offering of Common Stock (NASDAQ:IMDZ)
www.4-traders.com - September 16 at 9:31 AM
streetinsider.com logoImmune Design (IMDZ) Plans Public Offering of Common Stock (NASDAQ:IMDZ)
www.streetinsider.com - September 15 at 8:46 AM
publicnow.com logoImmune Design Announces Proposed Public Offering of Common Stock (NASDAQ:IMDZ)
www.publicnow.com - September 14 at 5:42 PM
biz.yahoo.com logoIMMUNE DESIGN CORP. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:IMDZ)
biz.yahoo.com - September 14 at 5:42 PM
bizjournals.com logoBiotech stocks reeling after Hillary Clinton criticizes drug prices (NASDAQ:IMDZ)
www.bizjournals.com - August 25 at 10:38 AM
live-pr.com logoNew Study: Immune Design Corp. (IMDZ) - Financial and Strategic SWOT Analysis Review (NASDAQ:IMDZ)
www.live-pr.com - August 24 at 8:42 AM
capitalcube.com logoETF’s with exposure to Immune Design Corp. : August 22, 2016 (NASDAQ:IMDZ)
www.capitalcube.com - August 22 at 5:40 PM
capitalcube.com logoImmune Design Corp. :IMDZ-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:IMDZ)
www.capitalcube.com - August 12 at 5:42 PM
seekingalpha.com logoImmune Design's (IMDZ) CEO Carlos Paya on Q4 2016 Results - Earnings Call Transcript (NASDAQ:IMDZ)
seekingalpha.com - August 11 at 8:39 AM
sg.finance.yahoo.com logoImmune Design reports 2Q loss (NASDAQ:IMDZ)
sg.finance.yahoo.com - August 10 at 8:29 AM
publicnow.com logoImmune Design Reports Second Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:IMDZ)
www.publicnow.com - August 9 at 5:46 PM
biz.yahoo.com logoQ2 2016 Immune Design Corp Earnings Release - After Market Close (NASDAQ:IMDZ)
biz.yahoo.com - August 9 at 8:36 AM
finance.yahoo.com logoImmune Design (IMDZ): Stock to Disappoint on Q2 Earnings? (NASDAQ:IMDZ)
finance.yahoo.com - August 5 at 8:35 AM
twst.com logoImmune Design Corp.: Immune Design to Report Second Quarter 2016 Financial Results (NASDAQ:IMDZ)
www.twst.com - August 2 at 5:51 PM
publicnow.com logoImmune Design to Report Second Quarter 2016 Financial Results (NASDAQ:IMDZ)
www.publicnow.com - August 2 at 10:26 AM
capitalcube.com logoETF’s with exposure to Immune Design Corp. : July 21, 2016 (NASDAQ:IMDZ)
www.capitalcube.com - July 21 at 2:08 PM
fxpips.com logoNew Market Lows Stock Leaders – AVGR, CLDC, IMDZ, RGNX, IMGN, CVI, XPLR (NASDAQ:IMDZ)
www.fxpips.com - July 14 at 9:07 AM
biz.yahoo.com logoIMMUNE DESIGN CORP. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:IMDZ)
biz.yahoo.com - July 1 at 5:13 PM
publicnow.com logoImmune Design Appoints Susan L. Kelley, M.D. to Board of Directors (NASDAQ:IMDZ)
www.publicnow.com - June 16 at 8:39 AM
nasdaq.com logoAnalysts Forecast 33% Upside For IBB (NASDAQ:IMDZ)
www.nasdaq.com - June 8 at 5:54 PM
publicnow.com logoImmune Design Releases New PFS, OS and TME Data from Trials of Three Immuno-Oncology Product Candidates (NASDAQ:IMDZ)
www.publicnow.com - June 8 at 8:08 AM
finance.yahoo.com logoImmune Design Announces Upcoming Events (NASDAQ:IMDZ)
finance.yahoo.com - June 1 at 8:00 AM
finance.yahoo.com logoImmune Design (IMDZ) Q1 Earnings: What Awaits the Stock? (NASDAQ:IMDZ)
finance.yahoo.com - May 6 at 7:16 PM
biz.yahoo.com logoIMMUNE DESIGN CORP. Files SEC form 10-K, Annual Report (NASDAQ:IMDZ)
biz.yahoo.com - March 15 at 6:09 AM
finance.yahoo.com logoImmune Design Loss Wider than Expected, Pipeline in Focus (NASDAQ:IMDZ)
finance.yahoo.com - March 11 at 9:30 AM
sg.finance.yahoo.com logoImmune Design reports 4Q loss (NASDAQ:IMDZ)
sg.finance.yahoo.com - March 10 at 4:29 PM
biz.yahoo.com logoIMMUNE DESIGN CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib (NASDAQ:IMDZ)
biz.yahoo.com - March 10 at 4:23 PM
finance.yahoo.com logoImmune Design Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update (NASDAQ:IMDZ)
finance.yahoo.com - March 10 at 4:01 PM
biz.yahoo.com logoQ4 2015 Immune Design Corp Earnings Release - After Market Close (NASDAQ:IMDZ)
biz.yahoo.com - March 10 at 7:07 AM
finance.yahoo.com logoWhat Awaits Immune Design (IMDZ) this Earnings Season? (NASDAQ:IMDZ)
finance.yahoo.com - March 8 at 10:10 AM
finance.yahoo.com logoImmune Design’s GLAAS™ Platform Shown to Modulate the Allergic Immune Response (NASDAQ:IMDZ)
finance.yahoo.com - March 4 at 8:00 AM
finance.yahoo.com logoImmune Design to Report Fourth Quarter and Year End 2015 Financial Results (NASDAQ:IMDZ)
finance.yahoo.com - March 3 at 8:00 AM
finance.yahoo.com logoImmune Design to Present at Cowen and Company 36th Annual Health Care Conference (NASDAQ:IMDZ)
finance.yahoo.com - February 29 at 8:00 AM
equities.com logoImmune Design Corp (IMDZ) is Trading Higher on Unusual Volume for February 24 - Equities.com (NASDAQ:IMDZ)
www.equities.com - February 26 at 10:24 AM
News IconDoes Immune Design Corp Have Any Gas After Today's Huge Decline? - Franklin Independent (NASDAQ:IMDZ)
www.franklinindependent.com - February 20 at 2:55 PM
biz.yahoo.com logoIMMUNE DESIGN CORP. Files SEC form 8-K/A, Financial Statements and Exhibits (NASDAQ:IMDZ)
biz.yahoo.com - February 16 at 4:40 PM
streetinsider.com logoImmune Design (IMDZ) Issues Positive Update from Ongoing CMB305 and G100 Phase 1s (NASDAQ:IMDZ)
www.streetinsider.com - February 9 at 1:31 PM
finance.yahoo.com logo8:03 am Immune Design reports 'Positive' Topline Data From Three Phase 1 Clinical Trials of Immuno-oncology Product Candidates (NASDAQ:IMDZ)
finance.yahoo.com - February 9 at 8:03 AM
finance.yahoo.com logoImmune Design Announces Positive Topline Data From Three Phase 1 Clinical Trials of Immuno-oncology Product Candidates (NASDAQ:IMDZ)
finance.yahoo.com - February 9 at 8:00 AM
finance.yahoo.com logoImmune Design to Present at Leerink Partners 5th Annual Global Healthcare Conference (NASDAQ:IMDZ)
finance.yahoo.com - February 4 at 8:00 AM
thestreet.com logoImmune Design is Now Oversold (IMDZ) (NASDAQ:IMDZ)
www.thestreet.com - February 3 at 12:42 PM
finance.yahoo.com logoGenocea Doses Patients in Phase IIb Study on GEN-003 (NASDAQ:IMDZ)
finance.yahoo.com - February 1 at 7:02 PM
finance.yahoo.com logoImmunoGen Posts Wider-than-Expected Loss, Retains View (NASDAQ:IMDZ)
finance.yahoo.com - February 1 at 10:10 AM
finance.yahoo.com logoImmune Design Corp. (IMDZ) (NASDAQ:IMDZ)
finance.yahoo.com - January 29 at 12:40 PM
finance.yahoo.com logoImmune Design Posts Narrower-Than-Expected Loss for Q3 (NASDAQ:IMDZ)
finance.yahoo.com - November 13 at 10:35 AM

Social

Immune Design Corp. (NASDAQ:IMDZ) Chart for Saturday, October, 1, 2016


Last Updated on 10/1/2016 by MarketBeat.com Staff